Zydus Lifesciences informs about press release

22 Jan 2026 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated January 22, 2026, titled ‘Zydus launches the world’s first biosimilar of Nivolumab, ‘Tishtha™’, in India to treat multiple cancers’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

883.85 7.75 (0.88%)
22-Jan-2026 16:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1374.60
Zydus Lifesciences 883.85
Lupin 2165.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×